SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
41 hedge funds and large institutions have $45.8M invested in scPharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 13 funds opening new positions, 14 increasing their positions, 5 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
56% less capital invested
Capital invested by funds: $103M → $45.8M (-$57.4M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
41
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$1.09M | |
| 2 | +$337K | |
| 3 | +$298K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$169K |
| 5 |
CG
Colony Group
Boston,
Massachusetts
|
+$131K |
Top Sellers
| 1 | -$3.79M | |
| 2 | -$2.48M | |
| 3 | -$692K | |
| 4 |
D.E. Shaw & Co
New York
|
-$545K |
| 5 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
-$501K |